Latest Schedule 13G passive stakes

Driehaus Capital Management LLC has reported beneficial ownership of 6.08% of Cardinal Infrastructure Group Inc.'s Class A Common Stock as of June 30, 2026.

Driehaus Capital Management LLC has disclosed beneficial ownership of 6.96% of Cue Biopharma, Inc.'s common stock, holding 292,144 shares.

Driehaus Capital Management LLC has amended its Schedule 13G filing to report a decrease in its beneficial ownership of Definium Therapeutics, Inc. common stock to 5.36% as of June 30, 2026.

Atika Capital Management LLC and Brad Farber have jointly filed a Schedule 13G, disclosing a beneficial ownership of 5.1% in JATT II Acquisition Corp.

Driehaus Capital Management LLC has amended its Schedule 13G filing to report an increased beneficial ownership of Septerna, Inc. common stock to 9.83%.

The State of Wisconsin Investment Board has disclosed its beneficial ownership of 4.98% of Liberty Media Corp's Series A Liberty Formula One Common Stock as of June 30, 2026.

Carlyle Group entities report a change in beneficial ownership of SunPower Inc. common stock, now holding 4.4% of the outstanding shares.

Carlyle Group entities report a change in beneficial ownership of SunPower Inc. common stock, now holding 4.4% of the outstanding shares.

Martine A. Rothblatt has increased her beneficial ownership of United Therapeutics Corp. common stock to 5.3%, holding 2,333,721 shares.

BCLS Fund III Investments, LP has reported a beneficial ownership of 8,448,158 shares, representing 9.8% of Heartflow, Inc.'s common stock as of June 30, 2026.

Bain Capital Life Sciences Opportunities III, L.P. has disclosed a beneficial ownership of 9.99% in Cabaletta Bio, Inc., primarily through warrants and common stock, subject to a beneficial ownership blocker.

Bain Capital Life Sciences Opportunities III, LP reports a 4.75% ownership stake in Kyverna Therapeutics, Inc. as of June 30, 2026.

Bain Capital Life Sciences Funds report a combined 18.48% ownership in Rapid Micro Biosystems, Inc. Class A Common Stock as of June 30, 2026.

Tencent Holdings Limited and its subsidiary Min River Investment Limited have filed an updated Schedule 13G, detailing their substantial beneficial ownership and voting power over Tencent Music Entertainment Group's Class A Ordinary Shares.

Index Ventures Life VI (Jersey) L.P., Yucca (Jersey) SLP, and Index Venture Life Associates VI Ltd have filed an amendment to Schedule 13G, confirming they beneficially own less than 5% of Centessa Pharmaceuticals' ordinary shares as of June 30, 2026.

Jianfeng Xu and associated entities have reported an increased beneficial ownership in Yalla Group Limited, now holding 8.7% of Class A ordinary shares.

Index Ventures entities have collectively reported beneficial ownership of 12.3% of Figma's Class A common stock, signaling substantial institutional confidence.

Tencent entities report updated beneficial ownership of Bilibili Inc. Class Z Ordinary Shares as of June 30, 2026.

Khrom Investments Fund, LP, Khrom Capital Management LLC, and Eric Khrom have collectively reported a beneficial ownership of 653,914 shares, representing 0.72% of Acadia Healthcare Company, Inc.

Tencent Holdings Ltd. and its subsidiary THL A12 Limited have reported an increased beneficial ownership of Horizon Quantum Holdings Ltd.'s Class A Ordinary Shares, now holding 11.1% of the outstanding shares.

Broad Bay Capital Management, LP has filed a Schedule 13G, disclosing beneficial ownership of 2,046,239 shares, representing 3.87% of the Series C Common Stock of Atlanta Braves Holdings, Inc.

Polar Capital Holdings Plc and Polar Capital LLP have reported beneficial ownership of 5.28% of Arcutis Biotherapeutics, Inc. common stock.

An amended Schedule 13G filing reveals updated beneficial ownership details for Ribbit Capital entities and Meyer Malka concerning Wealthfront Corp. common stock.

Tao Yang, Cheerio Investments Limited, and YooYoo Limited report combined beneficial ownership of 43.2% of Yalla Group Limited's Class A ordinary shares as of June 30, 2026.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 5.3% of Beyond Air, Inc.'s common stock, including shares issuable upon warrant exercise.

Balyasny Asset Management L.P. and affiliated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of 6.43% of TXNM Energy, Inc. common stock as of June 30, 2026.

Balyasny Asset Management L.P. and its affiliates have reported an increase in their beneficial ownership of Talkspace, Inc. common stock, now holding 4.09% of the outstanding shares.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 3,122,552 shares, representing 6.35% of SkyWater Technology, Inc.'s common stock.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 3,626,113 shares, representing 5.93% of Sagimet Biosciences Inc.'s common stock.

Balyasny Asset Management L.P. and affiliated entities have reported an adjustment in their beneficial ownership of SAB Biotherapeutics, Inc. common stock, now holding 9.45%.